跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NDUVRA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NDUVRA
Authorized
STANDARD
NDUVRA
Dermavant Sciences GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e43d57de269f72cc
Company
Dermavant Sciences GmbH
Type
Standard
Approval Details
Approval Id
e43d57de269f72cc
Drug Approval Canada Name
NDUVRA
Product Name
NDUVRA
Status
Approved
Status Date
2025-04-04
Din
02448254
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:24.12
Atc Original
D05AX07 TAPINAROF
Atc Name
d 05 ax 07
Aig Number
0266685001
Company Name
Dermavant Sciences GmbH
Company Address
Viaduktstrasse 8, Basel, Switzerland, 4051
Company Detail Path
/organization/dermavant-sciences-gmbh
Company Information
Pharmaceutical Company Name
Dermavant Sciences GmbH
Country Name
Switzerland
Province Name
California
City Name
加利福尼亚州洛杉矶县
Address
Viaduktstrasse 8
Website
https://dermavant.com
Active Ingredients
TAPINAROF
1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e43d57de269f72cc
Type
Standard
Back to Health Canada Approvals